DDInter622 DDInter1180
A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Edrophonium {u} (Compound) resembles {v} (Compound) Metaraminol
Edrophonium {u} (Compound) resembles {v} (Compound) Tapentadol
Edrophonium {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Neostigmine
Edrophonium {u} (Compound) binds {v} (Gene) BCHE
Edrophonium {u} (Compound) upregulates {v} (Gene) IL1R2
Edrophonium {u} (Compound) downregulates {v} (Gene) MAP7
Edrophonium {u} (Compound) causes {v} (Side Effect) Conjunctival hyperaemia
Edrophonium {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pyridostigmine
Edrophonium (Compound) resembles Metaraminol (Compound)
Edrophonium (Compound) resembles Tapentadol (Compound)
Edrophonium may cause a moderate interaction that could exacerbate diseases when taken with Neostigmine
Edrophonium (Compound) binds BCHE (Gene)
Edrophonium (Compound) upregulates IL1R2 (Gene)
Edrophonium (Compound) downregulates MAP7 (Gene)
Edrophonium (Compound) causes Conjunctival hyperaemia (Side Effect)
Edrophonium may cause a moderate interaction that could exacerbate diseases when taken with Pyridostigmine